Personal information
Activities
Employment (4)
2023-02
to
present
|
Associate Professor
(Department of Medicine)
Employment
Source:
Thomas Agoritsas
2017-10
to
present
|
Attending Physician
(Division of General Internal Medicine, Department of Medicine)
Employment
Source:
Thomas Agoritsas
2017-08
to
present
|
Chair
Employment
Source:
Thomas Agoritsas
2016-07
to
present
|
Part-time Professor
(Department of Health Research Methods, Evidence, and Impact (HEI), Faculty of Science)
Employment
Source:
Thomas Agoritsas
Education and qualifications (5)
2015-11
|
PhD
(Department of Health Research Methods, Evidence, and Impact (HEI), Faculty of Science)
Qualification
Source:
Thomas Agoritsas
2011-12
|
Board certification in General Internal Medicine
Qualification
Source:
Thomas Agoritsas
2011-02
|
MD: Doctoral Thesis in Medicine
(Faculty of Medicine)
Qualification
Source:
Thomas Agoritsas
1999-10
to
2006-01
|
Medical Diploma
(Faculty of Medicine)
Qualification
Source:
Thomas Agoritsas
2002-07
|
Certificate in Epidemiology & Biostatistics
Qualification
Source:
Thomas Agoritsas
Professional activities (7)
2025-03
to
present
|
Expert member
(Science and Health Commission (Comission Sciences et Santé))
Service
Source:
Thomas Agoritsas
2020-04-01
to
present
|
Expert guideline methodologist
Service
Source:
Thomas Agoritsas
2018-01-01
to
present
|
Expert panel member
Service
Source:
Thomas Agoritsas
2016-03-01
to
present
|
Co-founder and Co-leader of the BMJ Rapid Recommendations
Service
Source:
Thomas Agoritsas
2015-01-01
to
present
|
Deputy Editor at the American College of Physicians Journal Club (ACP JC)
Service
Source:
Thomas Agoritsas
2011
to
present
|
Member
Membership
Source:
Thomas Agoritsas
2008
to
present
|
Member
Membership
Source:
Thomas Agoritsas
Funding (20)
2025-01
to
2027-01
|
Grant
Canadian Institutes of Health Research
(ON, ON, CA)
Source:
Thomas Agoritsas
2025-01
to
2027-01
|
Grant
Geneva League Against Cancer
(Geneva, Geneva, CH)
Source:
Thomas Agoritsas
2024-01
to
2026-01
|
Grant
Fondation Leenaards
(Lausanne, Vaud, CH)
Source:
Thomas Agoritsas
2023-04-01
to
2027-03-31
|
Grant
European Commission
(Brussels, BE)
Source:
Thomas Agoritsas
via
DimensionsWizard
2023-01-01
to
2025-12-31
|
Grant
Swiss National Science Foundation
(Bern, CH)
Source:
Thomas Agoritsas
via
DimensionsWizard
2023-01
to
2024-01
|
Grant
HUG
(Geneva, Geneva, CH)
Source:
Thomas Agoritsas
2022-09-01
to
2027-08-31
|
Grant
European Commission
(Brussels, BE)
Source:
Thomas Agoritsas
via
DimensionsWizard
2022-09-01
to
2027-08-31
|
Grant
European Commission
(Brussels, BE)
Source:
Thomas Agoritsas
via
DimensionsWizard
2022-04-01
to
2027-03-31
|
Grant
Canadian Institutes of Health Research
(Ottawa, CA)
Source:
Thomas Agoritsas
via
DimensionsWizard
2022-04-01
to
2025-07-31
|
Grant
European & Developing Countries Clinical Trials Partnership
(The Hague, NL)
GRANT_NUMBER:
RIA2020S-3303
Source:
Thomas Agoritsas
via
DimensionsWizard
2021-09-01
to
2026-08-31
|
Grant
Swiss National Science Foundation
(Bern, CH)
Source:
Thomas Agoritsas
via
DimensionsWizard
2021-01-01
to
present
|
Grant
Southern and Eastern Norway Regional Health Authority
(Hamar, NO)
Source:
Thomas Agoritsas
via
DimensionsWizard
2020-06-01
to
2022-10-31
|
Grant
Swiss National Science Foundation
(Bern, CH)
Source:
Thomas Agoritsas
via
DimensionsWizard
2020-04-01
to
2022-03-31
|
Grant
Canadian Institutes of Health Research
(Ottawa, CA)
Source:
Thomas Agoritsas
via
DimensionsWizard
2020-04-01
to
2021-03-31
|
Grant
Canadian Institutes of Health Research
(Ottawa, CA)
Source:
Thomas Agoritsas
via
DimensionsWizard
2019-01
to
2021-01
|
Grant
HUG
(Geneva, Geneva, CH)
Source:
Thomas Agoritsas
2018-01
to
2020-01
|
Grant
HUG
(Geneva, Geneva, CH)
Source:
Thomas Agoritsas
2017-01
to
2019-01
|
Grant
HUG
(Geneva, Geneva, CH)
Source:
Thomas Agoritsas
2013-01-01
to
2019-12-31
|
Grant
Southern and Eastern Norway Regional Health Authority
(Hamar, NO)
Source:
Thomas Agoritsas
via
DimensionsWizard
2012-06-01
to
2013-05-31
|
Grant
Swiss National Science Foundation
(Bern, CH)
Source:
Thomas Agoritsas
via
DimensionsWizard